Geschreven door studenten die geslaagd zijn Direct beschikbaar na je betaling Online lezen of als PDF Verkeerd document? Gratis ruilen 4,6 TrustPilot
logo-home
Tentamen (uitwerkingen)

NR 565 / NR 565 Advanced Pharmacology Care of the Fundamentals Final Exam | Chamberlain University | Endocrinology, Respiratory, Gastroenterology, Infectious Disease, Immunology | Questions and Answers with Verified Rationales | Get HighScore | Instant Do

Beoordeling
-
Verkocht
-
Pagina's
55
Cijfer
A+
Geüpload op
21-04-2026
Geschreven in
2025/2026

GET HIGHSCORE on the NR 565 Advanced Pharmacology Care of the Fundamentals Final Exam (Weeks 5-8) at Chamberlain University with this comprehensive test bank featuring verified questions and answers with detailed rationales. The NR 565 final exam is non-cumulative, consisting of 100 multiple-choice questions with a 120-minute time allotment (1.2 minutes per question), covering content from Weeks 5 through 8 of the course . The exam will be available from Wednesday Week 8 at 12:01 am MT until Saturday Week 8 at 11:59 pm MT . This resource covers the four key content areas: Week 5 (Endocrine Disorders), Week 6 (Respiratory Conditions), Week 7 (Gastrointestinal Conditions), and Week 8 (Infectious Disease & Immunology) . MASTER ENDOCRINOLOGY (WEEK 5 - CHAPTERS 48-49) Type 2 Diabetes Diagnosis: A fasting plasma glucose of 130 mg/dL and a repeat value of 128 mg/dL meets the criteria for diabetes mellitus, as fasting plasma glucose ≥126 mg/dL on two separate occasions is diagnostic in the absence of acute stress . Initial Pharmacologic Approach for Type 2 Diabetes: For a newly diagnosed patient with A1C of 7.4% and no significant comorbidities, metformin monotherapy is most appropriate as first-line therapy in combination with diet and exercise. The American Diabetes Association (ADA) recommends metformin as first-line pharmacologic therapy due to its efficacy, safety, low cost, low risk of hypoglycemia, and lack of weight gain . Metformin GI Side Effects: A patient on metformin reporting significant nausea and diarrhea should be instructed to take the medication with the largest meal of the day. Gastrointestinal side effects are dose-dependent and can be minimized by taking with food, starting with a low dose, and titrating slowly . Diagnostic Criteria for Diabetes Mellitus: All four criteria are diagnostic: Fasting plasma glucose ≥126 mg/dL, random plasma glucose ≥200 mg/dL with symptoms, oral glucose tolerance test ≥200 mg/dL, or hemoglobin A1C ≥6.5% . A1C Monitoring Frequency: When stable, A1C should be monitored every 6 months. When A1C is 7% or greater, A1C should be monitored every 3 months . Treatment Intensification for Elevated A1C: When a patient with type 2 diabetes has an A1C of 9.5% despite being on metformin and glipizide with eGFR 45 mL/min, the most appropriate next step is to add basal insulin (e.g., glargine). Adding insulin earlier helps preserve beta-cell function while continuing oral agents, especially metformin . A1C Goals: General A1C goal is below 7%. For older adults with moderate comorbidities and life expectancy less than 10 years, recommended A1C goal is 7.5-8%; 8-8.5% for older patients with complex medical issues. A patient with recurrent severe hypoglycemia events should have an A1C goal of 8% . Pioglitazone (TZD) : Decreases insulin resistance, increases glucose uptake by muscle/adipose tissue, and decreases glucose production by the liver. Carries a black box warning for severe heart failure due to fluid retention. Contraindications include DKA, history of bladder cancer, Type 1 DM, hematuria, hypersensitivity, and hepatic impairment . Sulfonylureas (Glipizide) : Promote insulin secretion by the pancreas; significant risk of hypoglycemia. Should not be used during pregnancy or with liver or renal impairments. When starting a sulfonylurea, the most important adverse effect to emphasize during patient education is hypoglycemia, as sulfonylureas increase insulin secretion independent of glucose levels, carrying substantial risk of hypoglycemia especially with missed meals or renal impairment . GLP-1 Receptor Agonists (e.g., Exenatide, Liraglutide, Semaglutide) : Subcutaneous injections that cause increased insulin production, inhibit postprandial glucagon release, and increase satiety. Can be helpful in obese patients as they stimulate weight loss and suppression of appetite. Contraindications include pancreatitis, renal dysfunction, pregnancy, and personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. For a patient with type 2 diabetes and obesity already on metformin, a GLP-1 receptor agonist is best for promoting weight loss and improving glycemic control without hypoglycemia . SGLT2 Inhibitors (Canagliflozin, Empagliflozin, Dapagliflozin) : Limit reabsorption of glucose in renal tubules, block glucose reabsorption in the proximal nephron, and increase release of glucose in urine. Due to increased glucose in urine, patients are at higher risk for UTIs and vulvovaginal infections. May cause weight loss. Risk for volume depletion and hypotension; can lead to diabetic ketoacidosis. For a patient on canagliflozin reporting increased urination and mild genital itching, the most appropriate counseling point is to report signs of infection and maintain good perineal hygiene . DPP-4 Inhibitors (Sitagliptin, Saxagliptin, Linagliptin, Alogliptin) : Inhibit DPP-4 activity

Meer zien Lees minder
Instelling
Vak

Voorbeeld van de inhoud

1|Page




NR 565 / NR 565 Advanced Pharmacology Care of the
Fundamentals Final Exam | Chamberlain University |
Endocrinology, Respiratory, Gastroenterology, Infectious
Disease, Immunology |with Rationales

Exam Structure:

Subject: Advanced Pharmacology / Endocrinology / Respiratory / Gastroenterology /

Infectious Disease / Immunology

Source: NR 565 / NR 565 Advanced Pharmacology Care of the Fundamentals – Final

Exam (Chamberlain University) – 2026

Format: Open-ended questions with Correct Answers and rationales




1. What are the signs and symptoms of hypothyroidism?
Correct Answer: Face is pale, puffy, and expressionless. Skin is cold and
dry. Hair is brittle, and hair loss occurs. Heart rate and temperature are
lowered. The patient experiences lethargy, fatigue, and intolerance to cold.
Mentation may be impaired.
Rationale:
1. Hypothyroidism reduces metabolic rate, causing decreased heat production
(cold intolerance, low body temperature).
2. Accumulation of glycosaminoglycans in the skin causes myxedema (puffy
face, dry skin).
3. Bradycardia and lethargy result from decreased sympathetic nervous
system activity.
4. Cognitive impairment (brain fog) occurs due to reduced cerebral
metabolism.

2. What are the signs and symptoms of hyperthyroidism?
Correct Answer: Heart rate is rapid; possible arrhythmia/angina.
Nervousness, insomnia, rapid thought flow, and rapid speech. Skeletal
muscles may weaken and atrophy. Metabolic rate is raised, resulting in

, 2|Page


increased heat production, increased body temperature, intolerance to
heat, and skin that is warm and moist. Weight loss occurs if caloric intake
fails to match the increase in metabolic rate.
Rationale:
1. Increased thyroid hormone levels stimulate β-adrenergic receptors,
causing tachycardia and anxiety.
2. Hypermetabolism increases heat production (warm, moist skin, heat
intolerance).
3. Increased basal metabolic rate leads to weight loss despite normal or
increased appetite.
4. Muscle wasting results from protein catabolism.

3. What is severe hypothyroidism called?
Correct Answer: Myxedema
Rationale:
1. Myxedema is the most severe form of hypothyroidism.
2. It is characterized by non-pitting edema (myxedema) due to
accumulation of hydrophilic mucopolysaccharides in the skin.
3. Myxedema coma is a life-threatening emergency requiring immediate
treatment.

4. What is the treatment for hypothyroidism?
Correct Answer: Levothyroxine is the drug of choice for most patients who
require thyroid hormone replacement.
Rationale:
1. Levothyroxine (T4) is converted to the active hormone triiodothyronine
(T3) in peripheral tissues.
2. It has a long half-life (7 days), allowing once-daily dosing.
3. It is preferred over desiccated thyroid or liothyronine due to consistent
potency and predictable absorption.

5. What is the therapeutic goal of Levothyroxine (Synthroid)?
Correct Answer: Resolution of signs and symptoms of hypothyroidism and
restoration of normal laboratory values for serum thyroid-stimulating
hormone (TSH) and free thyroxine (T4).
Rationale:
1. TSH is the most sensitive marker for thyroid status in primary

, 3|Page


hypothyroidism.
2. Normalization of TSH indicates adequate replacement and prevents
overtreatment (iatrogenic hyperthyroidism).
3. Resolution of clinical symptoms confirms therapeutic effectiveness.

6. What are the major forms of hyperthyroidism?
Correct Answer: Graves' disease and toxic nodular goiter (also known as
Plummer disease).
Rationale:
1. Graves' disease is an autoimmune disorder caused by TSH receptor-
stimulating antibodies.
2. Toxic nodular goiter involves autonomously functioning thyroid nodules
that produce excess thyroid hormone independent of TSH.
3. Both cause hyperthyroidism but have different underlying mechanisms and
treatments.

7. What is Graves' disease?
Correct Answer: Most common cause of excessive thyroid hormone
secretion
Rationale:
1. Graves' disease accounts for 60-80% of hyperthyroidism cases.
2. It is caused by autoantibodies that stimulate the TSH receptor.
3. Associated with ophthalmopathy (exophthalmos) and pretibial myxedema.

8. What adjunctive therapy is good to prescribe to control symptoms
of hyperthyroidism other than thyroid-specific medications?
Correct Answer: β-Blockers and nonradioactive iodine may be used as
adjunctive therapy. β-Blockers suppress tachycardia by blocking β-
receptors on the heart. Nonradioactive iodine inhibits synthesis and release
of thyroid hormones.
Rationale:
1. β-Blockers (propranolol) control adrenergic symptoms (tachycardia,
tremor, anxiety) within hours.
2. Nonradioactive iodine (Lugol's solution, SSKI) rapidly inhibits thyroid
hormone release and is used before thyroidectomy.
3. These agents provide symptomatic relief while definitive therapy
(methimazole, radioactive iodine) takes effect.

, 4|Page



9. What are the monitoring needs and intervals for Levothyroxine?
Correct Answer: Check TSH 6-8 weeks after initiating therapy and after
any dosage change. Check TSH at least once a year after serum TSH is
stabilized.
Rationale:
1. TSH changes slowly; 6-8 weeks allows steady state to be reached after
dose adjustment.
2. Annual monitoring ensures continued euthyroidism and detects non-
adherence or changing thyroid status.
3. More frequent monitoring is needed during pregnancy or with interacting
medications.

10. How is hyperthyroidism treated?
Correct Answer: Thionamide drugs—methimazole and propylthiouracil
(PTU)—suppress synthesis of thyroid hormones.
Rationale:
1. Thionamides inhibit thyroid peroxidase, blocking iodination of
thyroglobulin and coupling of iodotyrosines.
2. Methimazole is preferred due to once-daily dosing and lower risk of
hepatotoxicity.
3. PTU is reserved for first trimester of pregnancy and thyroid storm.

11. What is the therapeutic goal of Methimazole?
Correct Answer: (1) reduction of thyroid hormone production in Graves'
disease, (2) control of hyperthyroidism until the effects of radiation on the
thyroid become manifest, (3) suppression of thyroid hormone production
before subtotal thyroidectomy, (4) treatment of thyrotoxic crisis.
Rationale:
1. Methimazole does not destroy thyroid tissue; it suppresses hormone
synthesis.
2. It is used as definitive therapy, as a bridge to radioactive iodine, or
preoperatively.
3. In thyroid storm, it is given with β-blockers, iodine, and corticosteroids.

12. What are the monitoring needs and intervals for Methimazole?

Geschreven voor

Instelling
Vak

Documentinformatie

Geüpload op
21 april 2026
Aantal pagina's
55
Geschreven in
2025/2026
Type
Tentamen (uitwerkingen)
Bevat
Vragen en antwoorden

Onderwerpen

$12.49
Krijg toegang tot het volledige document:

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF


Ook beschikbaar in voordeelbundel

Maak kennis met de verkoper

Seller avatar
De reputatie van een verkoper is gebaseerd op het aantal documenten dat iemand tegen betaling verkocht heeft en de beoordelingen die voor die items ontvangen zijn. Er zijn drie niveau’s te onderscheiden: brons, zilver en goud. Hoe beter de reputatie, hoe meer de kwaliteit van zijn of haar werk te vertrouwen is.
Honours Howard Community College
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
18
Lid sinds
2 maanden
Aantal volgers
0
Documenten
380
Laatst verkocht
6 dagen geleden

5.0

11 beoordelingen

5
11
4
0
3
0
2
0
1
0

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Bezig met je bronvermelding?

Maak nauwkeurige citaten in APA, MLA en Harvard met onze gratis bronnengenerator.

Bezig met je bronvermelding?

Veelgestelde vragen